Background: Oxaliplatin, a major drug in metastatic colorectal cancer (mCRC), is responsible for cumulative, dose-limiting peripheral neuropathy (PN). Whether the hepatic arterial infusion (HAI) route can limit oxaliplatin-induced PN in comparison with the intravenous (IV) route has not been specifically explored so far.
Methods: We compared the frequency and severity of PN in oxaliplatin-naive patients with mCRC included in trials that evaluated treatment with oxaliplatin administered either by HAI (ACCORD 04, CHOICE, OSCAR, and PACHA-01 trials) or by IV route (FFCD 2000-05 trial).
Nanomaterials (Basel)
August 2024
This paper proposes a unique configuration for an all-optical D Flip Flop (D-FF) utilizing a quasi-square ring resonator (RR) and T-Splitter, as well as NOT and OR logic gates within a 2-dimensional square lattice photonic crystal (PC) structure. The components realizing the all-optical D-FF comprise of optical waveguides in a 2D square lattice PC of 45 × 23 silicon (Si) rods in a silica (SiO) substrate. The utilization of these specific materials has facilitated the fabrication process of the design, diverging from alternative approaches that employ an air substrate, a method inherently unattainable in fabrication.
View Article and Find Full Text PDFSensors (Basel)
August 2024
Visible light communication (VLC) is becoming more relevant due to the accelerated advancement of optical fibers. Polymer optical fiber (POF) technology appears to be a solution to the growing demand for improved transmission efficiency and high-speed data rates in the visible light range. However, the VLC system requires efficient splitters with low power losses to expand the optical energy capability and boost system performance.
View Article and Find Full Text PDFObjectives: Approximately 40% of patients with colorectal cancer will develop liver metastases. Hepatic arterial infusion chemotherapy (HAIC) represents a valuable treatment option, with curative, palliative, or adjuvant intent. The aim of our study was to describe technical considerations, safety, and oncological outcomes of patients receiving HAIC.
View Article and Find Full Text PDF